Home>>Signaling Pathways>> GPCR/G protein>> Oxytocin Receptors>>OT-R antagonist 2 (Oxytocin receptor antagonist 2)

OT-R antagonist 2 (Oxytocin receptor antagonist 2) (Synonyms: Oxytocin receptor antagonist 2)

Catalog No.GC33540

OT-R antagonist 2 (Oxytocin receptor antagonist 2) is a nonpeptide low molecular weight OT-R antagonist.

Products are for research use only. Not for human use. We do not sell to patients.

OT-R antagonist 2 (Oxytocin receptor antagonist 2) Chemical Structure

Cas No.: 364071-16-9

Size Price Stock Qty
10mM (in 1mL DMSO)
$740.00
In stock
1mg
$252.00
In stock
5mg
$792.00
In stock
10mg
$1,260.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

OT-R antagonist 2 is a nonpeptide low molecular weight OT-R antagonist. OT-R antagonist 2 inhibitis IP3-Synthesis, rat OT-R (IC50 = 0.33 μM).IC50 value: 0.33μMTarget: oxytocin receptor

[1]. Cirillo R, et al. Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor. J Pharmacol Exp T [2]. William Nadler, et al. Method for preparing pyrrolidine oximes. WO/2005082848/A2. [3]. Serge Halazy, et al. Pharmaceutically active pyrrolidine derivatives as bax inhibitors.WO/2001074769/A1. [4]. Serge Halazy, et al. Pharmaceutically active pyrrolidine derivatives as bax inhibitors. WO/2001072705/A1.

Reviews

Review for OT-R antagonist 2 (Oxytocin receptor antagonist 2)

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for OT-R antagonist 2 (Oxytocin receptor antagonist 2)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.